Ipilimumab and Stereotactic Body Radiation Therapy (SBRT) in Advanced Solid Tumors

NCT02239900 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

143

Enrollment

OTHER

Sponsor class

Conditions

Liver Cancer
Lung Cancer

Interventions

DRUG: Ipilimumab
RADIATION: Stereotactic Body Radiation Therapy (SBRT)

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]